Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Open Label Study of Teriflunomide on Immune Cell Subsets in Relapsing Multiple Sclerosis
2012-005324-16Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of teriflunomide in multiple sclerosis (MS), sponsored by Sanofi. Primary endpoint: Change from baseline in lymphocyte subset parameters. Started Apr 2013; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2012-005324-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005324-16.